$OFIX
Orthofix Medical Inc.

2016 Q4 Form 10-Q Financial Statement

#000156459016026578 Filed on October 31, 2016

View on sec.gov

Income Statement

Concept 2016 Q4 2016 Q3 2015 Q3
Revenue $108.5M $98.50M $101.2M
YoY Change 3.74% -2.62% 0.16%
Cost Of Revenue $23.32M $19.88M $23.87M
YoY Change 8.92% -16.7% -5.55%
Gross Profit $85.22M $78.62M $77.29M
YoY Change 2.41% 1.72% 2.06%
Gross Profit Margin 78.51% 79.82% 76.41%
Selling, General & Admin $69.80M $60.30M $65.50M
YoY Change 1.9% -7.94% 9.51%
% of Gross Profit 81.91% 76.7% 84.75%
Research & Development $7.500M $6.900M $6.500M
YoY Change -1.32% 6.15% -1.1%
% of Gross Profit 8.8% 8.78% 8.41%
Depreciation & Amortization $5.300M $5.500M
YoY Change -74.64%
% of Gross Profit 6.22% 7.0%
Operating Expenses $77.80M $69.35M $73.15M
YoY Change 2.6% -5.2% 5.68%
Operating Profit $7.416M $9.271M $4.139M
YoY Change 0.49% 123.99% -36.4%
Interest Expense $400.0K $500.0K -$100.0K
YoY Change -300.0% -600.0% -125.32%
% of Operating Profit 5.39% 5.39% -2.42%
Other Income/Expense, Net -$4.200M -$600.0K -$1.700M
YoY Change 4100.0% -64.71% -0.99%
Pretax Income $3.700M $9.100M $2.300M
YoY Change -47.89% 295.65% -51.99%
Income Tax $8.800M -$1.300M $3.100M
% Of Pretax Income 237.84% -14.29% 134.78%
Net Earnings -$3.236M $9.896M -$1.371M
YoY Change -196.05% -821.81% -403.32%
Net Earnings / Revenue -2.98% 10.05% -1.36%
Basic Earnings Per Share -$0.18 $0.55 -$0.07
Diluted Earnings Per Share -$0.18 $0.54 -$0.07
COMMON SHARES
Basic Shares Outstanding 17.83M 18.85M
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q4 2016 Q3 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $39.60M $46.80M $63.70M
YoY Change -37.83% -26.53% 113.76%
Cash & Equivalents $39.57M $46.80M $63.69M
Short-Term Investments
Other Short-Term Assets $33.60M $20.50M $67.90M
YoY Change 7.69% -69.81% -40.33%
Inventory $63.30M $65.00M $57.80M
Prepaid Expenses
Receivables $57.80M $52.90M $56.20M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $194.4M $185.2M $245.5M
YoY Change -8.42% -24.56% -9.19%
LONG-TERM ASSETS
Property, Plant & Equipment $48.92M $51.90M $51.50M
YoY Change -6.48% 0.78% 3.8%
Goodwill $53.57M
YoY Change 0.0%
Intangibles $7.461M
YoY Change 40.72%
Long-Term Investments
YoY Change
Other Assets $20.46M $77.40M $46.60M
YoY Change 4.99% 66.09% 427.27%
Total Long-Term Assets $177.7M $190.9M $156.9M
YoY Change -5.45% 21.67% 11.51%
TOTAL ASSETS
Total Short-Term Assets $194.4M $185.2M $245.5M
Total Long-Term Assets $177.7M $190.9M $156.9M
Total Assets $372.1M $376.1M $402.4M
YoY Change -7.03% -6.54% -2.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $14.35M $14.40M $17.00M
YoY Change -12.48% -15.29% 28.79%
Accrued Expenses $6.155M
YoY Change -68.62%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $83.44M $83.30M $78.60M
YoY Change 1.77% 5.98% -3.42%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $25.19M $19.60M $26.70M
YoY Change -9.81% -26.59% 127.0%
Total Long-Term Liabilities $25.19M $19.60M $26.70M
YoY Change -9.81% -26.59% 127.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $83.44M $83.30M $78.60M
Total Long-Term Liabilities $25.19M $19.60M $26.70M
Total Liabilities $108.6M $102.9M $105.2M
YoY Change -1.17% -2.19% -0.78%
SHAREHOLDERS EQUITY
Retained Earnings $64.18M
YoY Change 2.6%
Common Stock $205.9M
YoY Change -12.01%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $263.5M $273.2M $297.2M
YoY Change
Total Liabilities & Shareholders Equity $372.1M $376.1M $402.4M
YoY Change -7.03% -6.54% -2.1%

Cashflow Statement

Concept 2016 Q4 2016 Q3 2015 Q3
OPERATING ACTIVITIES
Net Income -$3.236M $9.896M -$1.371M
YoY Change -196.05% -821.81% -403.32%
Depreciation, Depletion And Amortization $5.300M $5.500M
YoY Change -74.64%
Cash From Operating Activities $6.300M $17.00M $17.50M
YoY Change -63.16% -2.86% -3.31%
INVESTING ACTIVITIES
Capital Expenditures -$4.000M -$3.900M -$7.600M
YoY Change -40.3% -48.68% 46.15%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$4.000M -$3.900M -$7.600M
YoY Change -40.3% -48.68% 13.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -8.400M -6.800M -1.700M
YoY Change -13.4% 300.0% -80.46%
NET CHANGE
Cash From Operating Activities 6.300M 17.00M 17.50M
Cash From Investing Activities -4.000M -3.900M -7.600M
Cash From Financing Activities -8.400M -6.800M -1.700M
Net Change In Cash -6.100M 6.300M 8.200M
YoY Change -971.43% -23.17% 203.7%
FREE CASH FLOW
Cash From Operating Activities $6.300M $17.00M $17.50M
Capital Expenditures -$4.000M -$3.900M -$7.600M
Free Cash Flow $10.30M $20.90M $25.10M
YoY Change -56.72% -16.73% 7.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
63663000
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2016Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17826136
CY2015Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
16391000
CY2015Q4 ofix Deferred Cost Of Sales Net Of Reserves
DeferredCostOfSalesNetOfReserves
4553000
CY2016Q3 us-gaap Line Of Credit
LineOfCredit
0
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-14369000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
539000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-3666000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9614000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
26539000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20980000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
219000
ofix Payments To Acquire Assets And Investments
PaymentsToAcquireAssetsAndInvestments
3613000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
15250000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
4800000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-31649000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3106000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2354000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1437000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1723000
us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
34424000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
54996000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
34370000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-2381000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
26879000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
63694000
CY2016Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
7838000
CY2015Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
5087000
CY2016Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
48358000
CY2015Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
42947000
CY2016Q3 ofix Deferred Cost Of Sales Net Of Reserves
DeferredCostOfSalesNetOfReserves
4008000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4
CY2016Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
4809000
CY2015Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
4976000
CY2016Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
6500000
CY2016Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
5800000
CY2015Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
6300000
CY2016Q3 ofix Accumulated Temporary Impairment On Debt Securities
AccumulatedTemporaryImpairmentOnDebtSecurities
2500000
us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToParent
50000
us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
304000
us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
331328
CY2016Q3 us-gaap Stock Issued During Period Shares Share Based Compensation Gross
StockIssuedDuringPeriodSharesShareBasedCompensationGross
181235
CY2015Q3 us-gaap Stock Issued During Period Shares Share Based Compensation Gross
StockIssuedDuringPeriodSharesShareBasedCompensationGross
43326
us-gaap Stock Issued During Period Shares Share Based Compensation Gross
StockIssuedDuringPeriodSharesShareBasedCompensationGross
710026
us-gaap Stock Issued During Period Shares Share Based Compensation Gross
StockIssuedDuringPeriodSharesShareBasedCompensationGross
271166
CY2016Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.140
CY2015Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.346
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.438
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
4.271
CY2016Q3 ofix Effective Income Tax Rate Continuing Operations Excluding Impact Of Discrete Items
EffectiveIncomeTaxRateContinuingOperationsExcludingImpactOfDiscreteItems
0.292
CY2015Q3 ofix Effective Income Tax Rate Continuing Operations Excluding Impact Of Discrete Items
EffectiveIncomeTaxRateContinuingOperationsExcludingImpactOfDiscreteItems
0.633
ofix Effective Income Tax Rate Continuing Operations Excluding Impact Of Discrete Items
EffectiveIncomeTaxRateContinuingOperationsExcludingImpactOfDiscreteItems
0.665
ofix Effective Income Tax Rate Continuing Operations Excluding Impact Of Discrete Items
EffectiveIncomeTaxRateContinuingOperationsExcludingImpactOfDiscreteItems
2.792
CY2016Q3 ofix Increase Decrease In Net Income From Continuing Operations
IncreaseDecreaseInNetIncomeFromContinuingOperations
2900000
ofix Increase Decrease In Net Income From Continuing Operations
IncreaseDecreaseInNetIncomeFromContinuingOperations
2900000
CY2016Q3 ofix Increase Decrease In Tax Expense From Continuing Operations
IncreaseDecreaseInTaxExpenseFromContinuingOperations
-2900000
ofix Increase Decrease In Tax Expense From Continuing Operations
IncreaseDecreaseInTaxExpenseFromContinuingOperations
-2900000
CY2016Q3 ofix Increase Decrease Earnings Per Share
IncreaseDecreaseEarningsPerShare
0.16
ofix Increase Decrease Earnings Per Share
IncreaseDecreaseEarningsPerShare
0.16
CY2016Q3 ofix Percentage Of Reported Increase Decrease
PercentageOfReportedIncreaseDecrease
-0.026
ofix Percentage Of Reported Increase Decrease
PercentageOfReportedIncreaseDecrease
0.032
CY2016Q3 ofix Net Margin
NetMargin
36900000
CY2016Q3 us-gaap Litigation Settlement Amount
LitigationSettlementAmount
3000000
us-gaap Loss Contingency Settlement Agreement Terms
LossContingencySettlementAgreementTerms
During the third quarter of 2016, the Company entered into an agreement to settle an outstanding commercial litigation matter, whereby the Company will receive a $3.0 million cash payment.
CY2016Q3 ofix Accrued Settlement Costs
AccruedSettlementCosts
800000
CY2015Q3 ofix Accrued Settlement Costs
AccruedSettlementCosts
300000
CY2014Q2 us-gaap Litigation Settlement Amount
LitigationSettlementAmount
-1300000
CY2016Q3 ofix Accrued Expenses And Other Liabilities Related To Discontinued Operation
AccruedExpensesAndOtherLiabilitiesRelatedToDiscontinuedOperation
5700000
CY2015Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
75000000
CY2016Q3 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
253063
CY2016Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
11100000
CY2016Q3 ofix Average Price Paid Per Share
AveragePricePaidPerShare
43.90
CY2016Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
8400000
CY2015Q3 ofix Net Margin
NetMargin
31157000
ofix Net Margin
NetMargin
104136000
ofix Net Margin
NetMargin
93393000

Files In Submission

Name View Source Status
0001564590-16-026578-index-headers.html Edgar Link pending
0001564590-16-026578-index.html Edgar Link pending
0001564590-16-026578.txt Edgar Link pending
0001564590-16-026578-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ofix-10q_20160930.htm Edgar Link pending
ofix-20160930.xml Edgar Link completed
ofix-20160930.xsd Edgar Link pending
ofix-20160930_cal.xml Edgar Link unprocessable
ofix-20160930_def.xml Edgar Link unprocessable
ofix-20160930_lab.xml Edgar Link unprocessable
ofix-20160930_pre.xml Edgar Link unprocessable
ofix-ex311_6.htm Edgar Link pending
ofix-ex312_8.htm Edgar Link pending
ofix-ex321_7.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending